TG Therapeutics (TGTX)

P/S ratio as of April 2025 (TTM): 18.0

According to TG Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 26.7. At the end of 2024 the company had a P/S ratio of 15.4.

P/S ratio history for TG Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	15.4	39.07%
2023	11.1	-98.21%
2022	618	52.11%
2021	406	-99.14%
2020	> 1000	490.44%
2019	> 1000	253.09%
2018	> 1000	-40.61%
2017	> 1000	128.07%
2016	> 1000	-60.53%
2015	> 1000	-9.4%
2014	> 1000	432.14%
2013	878	-82.21%
2012	> 1000
2011	N/A
2010	N/A
2009	N/A
2002	2.04	111.56%
2001	0.9636

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Dr. Reddy's RDY	3.03	-83.16%	🇮🇳 India
Alkermes ALKS	3.40	-81.16%	🇮🇪 Ireland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for TG Therapeutics (TGTX)

P/S ratio as of April 2025 (TTM): 18.0